SESSION 6
Pathology for risk stratification and treatment tailoring

Chairs: Hervé Bonnefoi (France), Giuseppe Viale (Italy)

  Evaluation of margins in DCIS and invasive carcinoma: The pathologist perspective

Stuart Schnitt, USA

  Integrating multigene signatures in the management of primary breast cancer: When do we need it?

Christos Sotiriou, Belgium

  Controversies in treatment selection for patients with equivocal ER and HER2 results

Giuseppe Viale, Italy

  Significance of tumor infiltrating lymphocytes in patients with HER2 positive and triple negative breast cancer

Carsten Denkert, Germany

Discussion